BioDuro, a global Contract Research, Development, and Manufacturing Organization (CRDMO), has entered into a partnership with Silicogenix (SGX) to enhance early-stage drug development. SGX is known for its proprietary small molecule design technology, which facilitates polypharmacology and non-traditional therapeutic approaches. The partnership
In the fast-paced world of drug development, time is often the most critical factor in bringing life-saving therapies to patients. Presented by BioDuro By leveraging strategic parallel workstreams, a single point of contact, and a unified quality system, we successfully
“Our goal is to be more than a service provider. We aim to be a strategic partner that grows with our clients from bench to bedside.” – Dr. Jim Li Dr. Jim Li, President of CMC Solutions at BioDuro, brings
BioDuro, a global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the opening of a specialised laboratory in Shanghai’s Waigaoqiao Free-Trade Zone. The new facility is designed for the synthesis of highly potent compounds at the hundred-gram scale, operating
BioDuro, a Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the opening of a fully-automated solid-phase peptide synthesis scale-up laboratory in Shanghai, China. Located at the Zhangjiang High-tech Park campus, the new facility enhances BioDuro’s peptide manufacturing capabilities, meeting
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
